Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Walking Fish Therapeutics

Request full access

Rapidly advancing cell-based therapeutics to treat serious diseases, concentrating on oncology and regenerative therapies

South San Francisco, United StatesFounded 2019Biotech & Life Sciences

About Walking Fish Therapeutics

Walking Fish Therapeutics (WFT) is a biotechnology startup that specializes in B cell engineering. The company has developed a unique platform that leverages the protein production capabilities of B cells to create therapeutics for a range of medical conditions. These include oncology, regenerative medicine, autoimmune disease, and recombinant antibody production.

The company's business model revolves around the production and commercialization of these therapeutic proteins. By engineering B cells to produce specific proteins, Walking Fish can create targeted treatments for various diseases. This includes engineered antibodies for infectious diseases, replacement proteins for deficiency diseases, immune-inhibitory proteins for autoimmune diseases, and regenerative proteins.

Walking Fish operates in the biotechnology market, serving clients in the healthcare sector. These clients can include hospitals, clinics, and other healthcare providers, as well as pharmaceutical companies that may be interested in the company's innovative protein therapies.

The company's revenue is likely generated through the sale of these therapies, as well as through partnerships and collaborations with other entities in the healthcare and pharmaceutical sectors. Walking Fish's business model is supported by a team of cell engineering, manufacturing, and clinical experts, led by repeat entrepreneur and CEO Lewis "Rusty" Williams.

In summary, Walking Fish Therapeutics is a pioneering biotech startup that harnesses the power of B cells to create innovative protein therapies for a range of medical conditions.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
South San Francisco, United States
Employees
10
Open positions
None listed
Dealroom signal
70.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Feb 2022 $73M $292M First Spark Ventures · Terra Magnum Capital Partners · Northpond Ventures ↗
SERIES AOther financing Sep 2021 $50M $200M Emerson Collective · Quan Capital · Quan Capital · Illumina Ventures —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Walking Fish Therapeutics website traffic

Latest recorded traffic for Walking Fish Therapeutics is 90 monthly website visits, down 94% over the last three months. Walking Fish Therapeutics's team declined 9.1% over the past year.

Latest monthly visits90 3-month web change-94% 1-year team growth-9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Walking Fish Therapeutics in the South San Francisco ecosystem

Live from Dealroom

The Walking Fish Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Emerson Collective
  • Quan Capital
  • Illumina Ventures
  • First Spark Ventures
  • Northpond Ventures
  • Terra Magnum Capital Partners
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Walking Fish Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Walking Fish Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.